Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Singapore Medical Group Ltd increase in interest in subsidiary


Wednesday, 7 May 2014 06:14am EDT 

Singapore Medical Group Ltd:Enters into sale and purchase agreement to acquire additional 20 pct interest in The Cancer Centre Pte Ltd (TCC) for consideration of S$900,000 from Dr Wong Seng Weng.Consideration is satisfied by issuance of 5,360,000 ordinary shares of Company at an issue price of $0.1679, representing discount of 2.7 pct from weighted average price of $0.1725 of shares traded on May 06, 2014, being market day preceding date of signing of sale and purchase agreement.Following acquisition, TCC became an 80 pct owned subsidiary of Company. 

Company Quote

0.19
-0.0010 -0.52%
22 Jul 2014